
The most common cause is nonalcoholic fatty liver disease (sometimes called nonalcoholic steatohepatitis or NASH), which can affect up to 30% of the U.S. population.
Other common liver causes include:
- alcoholic liver disease
- medication-associated liver injury
- viral hepatitis (hepatitis B and C)
- hemochromatosis


Pale stool and dark urine (click to enlarge the images). This is an example of "obstructive" jaundice with the classic constellation of tea-colored urine and clay-colored stool.
Less common liver causes include:
- alpha-1-antitrypsin deficiency (AAT)
- autoimmune hepatitis
- Wilson disease
Extrahepatic conditions can also cause elevated liver transaminase levels:
- thyroid disorders
- celiac disease
- hemolysis
- muscle disorders
Initial testing should include:
- fasting lipid profile (FLP)
- measurement of glucose
- serum iron and ferritin; total iron-binding capacity (TIBC)
- hepatitis B surface antigen and hepatitis C virus antibody
If above test results are normal, a trial of lifestyle modification is appropriate.
Additional testing may include:
- ultrasonography (USG) of liver
- alpha-1-antitrypsin (AAT) and ceruloplasmin
- serum protein electrophoresis (SPEP)
- antinuclear antibody (ANA), smooth muscle antibody (ASMA), and liver/kidney microsomal antibody type
GI evaluation and possible liver biopsy is recommended if transaminase levels remain elevated for more than 6 months.
References:
Causes and evaluation of mildly elevated liver transaminase levels. Oh RC, Hustead TR. Am Fam Physician. 2011 Nov 1;84(9):1003-8.